PHENYL-SUBSTITUTED ALKENOYLGUANIDIDES, PROCESS FOR THEIR PREPARATION, THEIR USE AS DRUGS OR DIAGNOSTIC AGENTS AND DRUGS CONTAINING THEM

    公开(公告)号:HRP970450B1

    公开(公告)日:2003-02-28

    申请号:HRP970450

    申请日:1997-08-21

    Applicant: HOECHST AG

    Abstract: Phenyl-substituted alkenyl-carboxylic acid guanidide compounds of formula (I) are new. T = a group (i); Ra = H, F, Cl, Br, I , CN, OH, OR6, 1-4C alkyl, Or-(CH2)aCbF2b+1, 3-8C cycloalkyl or NR7R8; r = 0 or 1; a = 0 - 4; b = 1 - 4; R6 = 1-4C alkyl, 1-4C perfluoroalkyl, 3-6C alkenyl, 3-8C cycloalkyl, phenyl or benzyl; where the phenyl nucleus is optionally substituted by 1 - 3 F, Cl, CF3, CH3, OCH3 or NR9R10 groups; R9, R10 = H, 1-4C alkyl or 1-4C perfluoroalkyl; R7, R8 = as for R6; or R7+R8 = (CH2)4 or (CH2)5, where one of the CH2 groups may be replaced by O, S, NH, N-CH3 or N-benzyl; Rb, Rc, Rd = as for Ra; x, y = 0 - 2; Rf = H, F, Cl, Br, I, CN, OR12, 1-8C alkyl, Op-(CH2)f-CgF2g+1, 3-8C cycloalkyl or 1-9C heteroaryl; p = 0 or 1; f = 0 - 4; g = 1 - 8; R12 = 1-8C alkyl, 1-4C perfluoroalkyl, 3-8C alkenyl, 3-8C cycloalkyl, phenyl or benzyl; where the phenyl nucleus may be substituted by 1 - 3 F, Cl, CF3, CH3, OCH3 or NR13R14 groups; R13, R14 = H, 1-4C alkyl or 1-4C perfluoroalkyl; Re = as for Rf; R1 = as for T, or is H, Ok-CmH2m+1, On-(CH2)p-CqF2q+1, F, Cl, Br, I, CN, CO-N=C(NH2)2, SOr1R17, SOr2-NR31R32, Ou-(CH2)v-C6H5, Ou2-(1-9C heteroaryl) (sic) or Su2-(1-9C heteroaryl) (sic); k, n = 0 or 1; m = 0-8; q = 1 - 8; p = 0-4; r1, r2 = 0 - 2; R31, R32 = H, 1-8C alkyl or 1-8C perfluoroalkyl, or R31+R32 = (CH2)4 or (CH2)5, where one of the CH2 groups may be replaced by O, S, NH, N-CH3 or N-benzyl; R17 = 1-8C alkyl; u, u2 = 0 or 1; v = 0- 4. The phenyl nucleus may be substituted by 1-3 F, Cl, CF3, CH3, OCH3, (CH2)w-NR21R22, NR18R19 or 1-9C heteroaryl groups ÄsicÜ. R18, R19, R21, R22 = 1-4C alkyl or 1-4C perfluoroalkyl; w = 1 - 4; The heterocycle of the 1-9C heteroaryl may be substituted by 1 - 3 F, Cl, CF3, CH3 or OCH3 groups. R2, R3, R4 and R5 = as for R1; or R1+R2 or R2+R3 = CH-CH=CH-CH, which is optionally substituted by 1 - 3 F, Cl, CF3, CH3, OCH3, (CH2)w2-NR24R25 or NR26R27; R24, R25, R26, R27 = H, 1-4C alkyl or 1-4C perfluoroalkyl; w2 = 1 - 4; provided that T is present 2-3 times in the molecule.

    SUBSTITUTED BENZYLOXYCARBONYL GUANIDINES,PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICINAL OR DIAGNOSTIC AGENTS AS WELL AS MEDICAMENTS CONTAINING THEM

    公开(公告)号:HRP960221B1

    公开(公告)日:2002-02-28

    申请号:HRP960221

    申请日:1996-05-15

    Applicant: HOECHST AG

    Abstract: Phenylalkyl (oxy or amino) carbonylguanidine cpds. of formula (I) are new. R1-R3 = Y-Phe, Py, Q-Phe', Het, SR25, OR25, NR25R26, CR25R26R27, En-CvH2v-G-A-R51, H, F, Cl, Br, I, CN, T(CH2)h(ClF2l+1), SOlR31, CONR32R33, COR34, SO2NR45R46, CF2R64, CFR65R66, CFÄ(CF2)qCF3ÜR65, CÄ(CF2)pCF3Ü=CR65R66, OR67, NR67R68, 1-8C alkyl, 2-8C alkenyl or (CH2)mR14; Phe = phenyl, (substd. by one R8 gp. and opt. substd. by 1 or 2 of R'); R' = F, Cl, CF3, Me, OH, OMe or NR15R16; Het = 1-9 heteroaryl, bonded by C or N (opt. substd. by 1-3 or R'); R15, R16, R56 = H or Me; Y = bond, CH2, O, S or NR9; R8 = SOa(NR98)bNR99R10 or SOa(NR98)bNR95-C(=NR94)NR92R93; a = 1 or 2; b = 0 or 1; a+b = 2; R10, R98, R99 = H, Me, benzyl, 2-8C alkyl (opt. substd. by NR11R12 or NR13-A'-NR37R38) or 0-8 alkyl (substd. by CR39R40-CR41R42A"NR43R44); or R99+R10 = 4-6C n-alkylene (opt. with one CH2 replace by O, S, NH, NMe or N-benzyl); A' = 2-8C alkylene; A" = 0-8C alkylene; R11-R13, R23, R24 R37, R38, R43, R44 = H, 1-8C alkyl or benzyl; R39-R42 = H, 4-8C alkyl, phenyl, 1-3C alkyl (opt. substd. by phenyl) (where the phenyl gps. are opt. substd. by F, Cl, CF3, Me or OMe); Py = pyrrol-(1,2 or 3)-yl (opt. substd. by 1-4 of F, Cl, Br, I, CN, 2-8C alkanoyl, 2-8C alkoxycarbonyl, CHO, COOH, CF3, Me or OMe); m, h, l, d, r, p, q = 0-2; s is not defined; R14 = 3-8C cycloalkyl or phenyl(opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR15R16); Q = bond, O, S or NR18; Phe' = phenyl (substd. by (CH2)kCHR17COR20 and opt. substd. by one or 2 R'); R17 = OR21 or NR21R22; R20 = OR23 or NR23R24; R22 = H, 1-8C alkyl, 1-8C alkanoyl, 1-8C alkoxycarbonyl, benzyl or benzoyloxycarbonyl; R21 = as R22 or trityl; k, z = 1-4; R25 = 0-2C alkyl substd. by Het or its N-oxide; R26, R27 = H as for R25, H or 1-4C alkyl; T = as Q but not butylimino; i = 2-6; R31 = 1-8C alkyl, 3-6C alkenyl, (CH2)nR48 or CF3; R32,R34,R45 = H or as for R31; n, v = 0-4; R47 R69-R71 = H or 1-3C alkyl; R48 = 3-7C cycloalkyl or phenyl (opt. substd. by 1-3 or F, Cl, CF3, Me, OMe and NR49R50); R33, R46 = H or 1-4C alkyl; or R32+R33, R45+R46 = (CH2)5 or (CH2)6 (both opt. with one CH2 replaced by O, S, NH, NMe or N-benzyl); R51 = basic, protonisable residue ( i.e. NR52R53, C(=NR54)NR52R51 or NR55-C(=NR54)NR52R53) or a basic 1-9C heteroaryl ring; R52-R55 = H or 1-4C alkyl or R52+R53 = C4H8 or A1; or R53+R54, R54+R55 or R52+R55 = C2H4 or A2; A1 =C5H10, C6H12 or C7H14 (all with one C atom opt. replaced by O, SOd or NR56); A2 = C3H6, C4H8 or C5H10 (all with one C opt. replaced by O, SOd or NR56); A = CeH2e (opt. with one C replaced by O, CO, CH(OR57), SOr, NR57,CON(R57), SO2N(R57), NH-CO-NR57 or SO2NHCONR57); e = 0-10; G = phenylene (opt. substd. by one or two of Me, OMe, F, Cl, Br, I, CF3, SOsMe or SOsNR61R62; w = 0 or 1; E = O, CO, CH(OR63), S, SO, SO2, NH, or NMe; R64 = 1-4C alkyl or 3-7C cycloalkyl; R67, R68 = H or 1-6C alkyl; or R67+R68 = (CH2)4-7, opt. with one CH2 replaced by O, S, SO2, NH, NMe or N-benzyl; R4, R5 = H, 1-4C alkyl, F, Cl, OR69, NR70R71 or CzF2z+1; X = O or NR72; R6, R7, R9, R18, R49, R50, R61, R62, R65, R66, R72, R92-R95 = H or 1-4C alkyl; provided that R1-R7 and R72 are not all H.

Patent Agency Ranking